Table 1.
The interactions for itraconazole with drugs.
Drug | The Impact of pH on Absorption | Reference |
---|---|---|
Omeprazole | Decrease of AUC0-24 and Cmax of itraconazole. | [18] |
The Impact of Interaction with CYP on Pharmacokinetic Parameters | ||
Ibrutinib | The inhibition of CYP3A4 by itraconazole results in 10-fold increase of AUC and 8.8-fold increase of Cmax for ibrutinib. | [22] |
Efavirenz | The induction of CYP3A4 activity by efavirenz led to decrease of exposure to itraconazole and its metabolite. | [24] |
Atorvasatatin | The inhibition of CYP3A4 by itraconazole resulted in the increase in AUC, the peak serum concentration and half-life of atorvastatin lactone. | [26] |
Oxycodone | The inhibition of the gut and liver CYP3A4 resulted in the increase in the exposure to oxycodone via inhibition of N-demetylation. | [28] |
Midazolam | The inhibition of CYP3A4 by itraconazole resulted in the increase in the concentration of midazolam. | [29] |
Alprazolam | The inhibition of CYP3A4 by itraconazole resulted in the increase in AUC and prolongation of half-life of alprazolam and decrease in the oral clearance. | [30] |
Haloperidol | Voriconazole increased of AUC of haloperidol for both genetic types—CYP2D6*10/*10 and CYP2D6*1/*1. | [31] |
Phenytoin | The inhibition of CYP2C9 by itraconazole increased the AUC of phenytoin by 10%. | [32] |